Simmons Bank’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.58M | Buy |
71,297
+17
| +0% | +$1.96K | 0.57% | 43 |
|
|
2025
Q4 | $7.5M | Buy |
71,280
+691
| +1% | +$64.9K | 0.5% | 52 |
|
|
2025
Q3 | $5.92M | Sell |
70,589
-3,928
| -5% | -$324K | 0.39% | 60 |
|
|
2025
Q2 | $5.9M | Buy |
74,517
+112
| +0.2% | +$8.9K | 0.42% | 58 |
|
|
2025
Q1 | $6.68M | Sell |
74,405
-7,728
| -9% | -$722K | 0.5% | 51 |
|
|
2024
Q4 | $8.17M | Sell |
82,133
-2,778
| -3% | -$286K | 0.6% | 44 |
|
|
2024
Q3 | $9.64M | Sell |
84,911
-1,826
| -2% | -$217K | 0.7% | 38 |
|
|
2024
Q2 | $10.7M | Sell |
86,737
-2,079
| -2% | -$268K | 0.81% | 28 |
|
|
2024
Q1 | $11.7M | Sell |
88,816
-960
| -1% | -$118K | 0.88% | 30 |
|
|
2023
Q4 | $9.79M | Sell |
89,776
-1,034
| -1% | -$107K | 0.8% | 31 |
|
|
2023
Q3 | $9.35M | Sell |
90,810
-158
| -0.2% | -$17K | 0.83% | 27 |
|
|
2023
Q2 | $10.5M | Sell |
90,968
-1,645
| -2% | -$187K | 0.88% | 25 |
|
|
2023
Q1 | $9.85M | Buy |
92,613
+2,467
| +3% | +$266K | 0.84% | 28 |
|
|
2022
Q4 | $10M | Sell |
90,146
-65
| -0.1% | -$6.64K | 0.86% | 26 |
|
|
2022
Q3 | $7.77M | Sell |
90,211
-1,077
| -1% | -$96.1K | 0.72% | 36 |
|
|
2022
Q2 | $8.32M | Sell |
91,288
-22,193
| -20% | -$1.97M | 0.73% | 34 |
|
|
2022
Q1 | $9.31M | Sell |
113,481
-1,954
| -2% | -$154K | 0.7% | 36 |
|
|
2021
Q4 | $8.85M | Sell |
115,435
-1,918
| -2% | -$153K | 0.62% | 38 |
|
|
2021
Q3 | $8.81M | Sell |
117,353
-10,106
| -8% | -$769K | 0.64% | 36 |
|
|
2021
Q2 | $9.91M | Sell |
127,459
-14,017
| -10% | -$1.04M | 0.72% | 28 |
|
|
2021
Q1 | $10.4M | Sell |
141,476
-8,282
| -6% | -$611K | 0.79% | 26 |
|
|
2020
Q4 | $11.7M | Sell |
149,758
-7,954
| -5% | -$608K | 0.93% | 21 |
|
|
2020
Q3 | $12.5M | Sell |
157,712
-3,155
| -2% | -$247K | 1.02% | 17 |
|
|
2020
Q2 | $11.9M | Buy |
160,867
+3,250
| +2% | +$245K | 0.98% | 17 |
|
|
2020
Q1 | $11.6M | Buy |
157,617
+14,537
| +10% | +$1.14M | 1.01% | 16 |
|
|
2019
Q4 | $12.4M | Sell |
143,080
-1,514
| -1% | -$124K | 1.11% | 19 |
|
|
2019
Q3 | $11.6M | Buy |
144,594
+3,651
| +3% | +$293K | 1.14% | 19 |
|
|
2019
Q2 | $11.3M | Sell |
140,943
-4,404
| -3% | -$337K | 1.09% | 20 |
|
|
2019
Q1 | $11.5M | Buy |
145,347
+772
| +0.5% | +$57.7K | 1.12% | 20 |
|
|
2018
Q4 | $10.5M | Buy |
144,575
+3,784
| +3% | +$267K | 1.18% | 20 |
|
|
2018
Q3 | $9.53M | Sell |
140,791
-156
| -0.1% | -$9.94K | 0.94% | 22 |
|
|
2018
Q2 | $8.16M | Buy |
140,947
+4,253
| +3% | +$240K | 0.74% | 27 |
|
|
2018
Q1 | $7.1M | Buy |
136,694
+18,710
| +16% | +$1.01M | 0.64% | 29 |
|
|
2017
Q4 | $6.33M | Sell |
117,984
-8,608
| -7% | -$477K | 0.64% | 29 |
|
|
2017
Q3 | $7.74M | Buy |
126,592
+1,017
| +0.8% | +$61.7K | 0.8% | 25 |
|
|
2017
Q2 | $7.68M | Buy |
125,575
+30,940
| +33% | +$1.88M | 0.86% | 20 |
|
|
2017
Q1 | $5.74M | Sell |
94,635
-846
| -0.9% | -$51.3K | 0.63% | 26 |
|
|
2016
Q4 | $5.36M | Sell |
95,481
-327
| -0.3% | -$19.1K | 0.6% | 32 |
|
|
2016
Q3 | $5.71M | Sell |
95,808
-113
| -0.1% | -$6.61K | 0.63% | 29 |
|
|
2016
Q2 | $5.27M | Buy |
95,921
+6,513
| +7% | +$347K | 0.59% | 30 |
|
|
2016
Q1 | $4.51M | Buy |
+89,408
| New | +$4.38M | 0.5% | 36 |
|
Other funds holding MRK
VCM
VPM
Simmons Bank's MRK Position: Q1 2026 in Review
Simmons Bank increased its Merck (MRK) stake by 0.02% in Q1 2026, buying an estimated $1.96K and bringing the position to 71,297 shares worth $8.58M. The position accounts for 0.57% of the portfolio, ranked #43.
Simmons Bank first reported a position in MRK in Q1 2016 and has held it in 41 quarters since. The position peaked at $12.5M in Q3 2020. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Simmons Bank held 71,297 shares of Merck worth $8.58M as of Q1 2026.
- Simmons Bank bought 17 Merck shares in Q1 2026, an estimated $1.96K.
- Merck made up 0.57% of Simmons Bank's portfolio in Q1 2026, its #43 holding.
- Simmons Bank first reported a position in Merck in Q1 2016 and has held it in 41 quarters since.
- Simmons Bank's Merck position peaked at $12.5M in Q3 2020.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Simmons Bank's 13F filing for Q1 2026, filed 23 Apr 2026.